MedWatch

Interim Lundbeck CEO: A strong financial statement

The Danish drug group Lundbeck continues on its course towards the best annual result in the company’s history. This gives rise to pride for CFO and interim CEO Anders Götzsche, who recently presented his first financial statement in position as interim head of the Danish company.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

2017 var et rekordår for kapitalrejsninger i Skandinavien

Skandinaviske life science-selskaber rejste ligeså mange penge i 2017 som i de tre foregående år tilsammen, viser en ny rapport fra svenske Industrifonden. Sverige førte ikke overraskende an, men der var også fremgang at spore i Danmark og Norge.

Related articles